ロード中...
Efficacy of Levofloxacin-Based Third-Line Therapy for the Eradication of Helicobacter pylori in Peptic Ulcer Disease
BACKGROUND/AIMS: The resistance rate of Helicobacter pylori is gradually increasing. We aimed to evaluate the efficacy of levofloxacin-based third-line H. pylori eradication in peptic ulcer disease. METHODS: Between 2002 and 2014, 110 patients in 14 medical centers received levofloxacin-based third-...
保存先:
| 出版年: | Gut Liver |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Editorial Office of Gut and Liver
2017
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347646/ https://ncbi.nlm.nih.gov/pubmed/27609487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl16099 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|